Brief: Pliant Therapeutics Provides Corporate Update And Reports Fourth Quarter 2022 Financial Results

Pliant Therapeutics

09/03/2023 21:52

March 9 (Reuters) - Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER 2022 FINANCIAL RESULTS
    * PLIANT THERAPEUTICS INC - $287.5 MILLION EQUITY FINANCING
EXTENDS RUNWAY INTO SECOND HALF OF 2026
    * PLIANT THERAPEUTICS INC - INTEGRIS-IPF 320 MG DOSE 24-WEEK
DATA
EXPECTED IN Q2 OF 2023
    * PLIANT THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.72

Source text for Eikon:  ID:nGNX9DZpH0 
Further company coverage:  PLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))